or Try an Advanced Search...

    Resistant Prostate Cancer Stocks List

    Symbol Grade Name % Change
    EXEL B Exelixis, Inc. -0.95
    CRDF B Cardiff Oncology, Inc. -21.43
    AMGN B Amgen Inc. 11.80
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Prostate Cancer Biotechnology Cancer Drugs Medicine Metastatic Castration Resistant Prostate Cancer Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Antineoplastic Drugs Blood Cells Bone Bone Disease Cancer Care Cancer Treatment Chemotherapy Clinic Clinical Medicine Colorectal Cancer Cyclopropanes

    Related ETFs - A few ETFs which own one or more of the above listed Resistant Prostate Cancer stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 15.08
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.46
    IBB C iShares Nasdaq Biotechnology Index Fund 9.43
    BIS C ProShares UltraShort Nasdaq Biotechnology 8.87
    PBE C PowerShares Dynamic Biotech & Genome 8.27
    View all Resistant Prostate Cancer ETFs...
    Compare ETFs
    Compare BIS to PBE Compare IBB to PBE Compare IBBQ to BIS

        Resistant Prostate Cancer Stocks Recent News

        Date Stock Title
        May 3 AMGN Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
        May 3 AMGN Dow Jones Soars 400 Points As Amgen, Apple Surge; Nvidia Jumps Again, Tempts New Buyers
        May 3 AMGN US STOCKS-Wall St gains after soft jobs data allays rate jitters
        May 3 AMGN Amgen stock rallies 13% on GLP-1 weight-loss drug update
        May 3 AMGN Amgen Knocks Novo Nordisk's Ozempic Stock Rally
        May 3 AMGN Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
        May 3 AMGN Amgen surges over confidence in early obesity drug results
        May 3 AMGN These Two Stocks Are Driving the Dow Friday
        May 3 AMGN Stocks to Watch Friday: Apple, Amgen, Coinbase, Block
        May 3 AMGN Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
        May 3 AMGN US STOCKS-Wall St set to open sharply higher on soft jobs data
        May 3 AMGN US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited
        May 3 AMGN US added 175,000 jobs in April, Apple’s stock rallies on earnings: Yahoo Finance
        May 3 AMGN Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
        May 3 AMGN Futures rise on Apple, Amgen boost; jobs data on tap
        May 3 AMGN US STOCKS-Futures rise on Apple, Amgen boost; jobs data on tap
        May 3 AMGN Novo slides as Amgen fuels obesity drug competition fears
        May 3 AMGN Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
        May 3 AMGN Amgen shares jump after teasing weight-loss drug data, rivals slip
        May 3 AMGN These Stocks Are Moving the Most Today
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Prostate Cancer Biotechnology Cancer Drugs Medicine Metastatic Castration Resistant Prostate Cancer Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Antineoplastic Drugs Blood Cells Bone Bone Disease Cancer Care Cancer Treatment Chemotherapy Clinic Clinical Medicine Colorectal Cancer Cyclopropanes
        Resistant Prostate Cancer

        Resistant prostate cancer is a type of prostate cancer that has become resistant to hormone therapy, which is the most common form of treatment for prostate cancer. This type of cancer is more difficult to treat and may require more aggressive treatments such as chemotherapy or radiation therapy.

        Browse All Tags